{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/breastfeeding-problems/how-up-to-date-is-this-topic/changes/","result":{"pageContext":{"chapter":{"id":"acf6ae76-da75-5e22-97ae-25b268d9bd76","slug":"changes","fullItemName":"Changes","depth":2,"htmlHeader":"<!-- begin field 012a9ff2-4d67-4d1e-acd2-744492ea77e1 --><h2>Changes</h2><!-- end field 012a9ff2-4d67-4d1e-acd2-744492ea77e1 -->","summary":null,"htmlStringContent":"<!-- begin item 11bd74d1-0b12-44d8-b18f-dbaf5250faa5 --><!-- begin field a62d2d19-2bc7-40a4-8293-20d87e3cc12a --><p><strong>May 2017</strong> — minor update. Recommendations on use of soft paraffin or purified lanolin cream revised to reflect evidence-base. </p><p><strong>December 2016 to January 2017 </strong>— reviewed. A literature search was conducted in November 2016 to identify evidence-based guidelines, UK policy, systematic reviews, and key randomized controlled trials published since the last revision of the topic. The topic has undergone significant restructuring. The section on prescribing information has been expanded. The scope of the topic has been reduced and the information on breast lumps and vitamin D supplementation has been removed, as this is covered in detail in the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/breast-cancer-recognition-referral/\">Breast cancer - recognition and referral</a> and <a class=\"topic-reference external-reference\" href=\"/topics/vitamin-d-deficiency-in-adults-treatment-prevention/\">Vitamin D deficiency in adults - treatment and prevention</a>. The lower age limit of the topic has been changed from 10 to 14 years.</p><!-- end field a62d2d19-2bc7-40a4-8293-20d87e3cc12a --><!-- end item 11bd74d1-0b12-44d8-b18f-dbaf5250faa5 -->","topic":{"id":"4d56065b-4316-58f6-aae8-5f7154ca6148","topicId":"c8e357d0-0bb7-413a-bc3b-caf10d9584ce","topicName":"Breastfeeding problems","slug":"breastfeeding-problems","lastRevised":"Last revised in May 2017","chapters":[{"id":"f183a7e4-fb16-5c51-8e82-8040a8fd2543","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"6c3771ea-501b-5f7e-8d4f-d1142d882322","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"2e3dcd26-e84a-59d0-8323-03f0685cd6a1","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"acf6ae76-da75-5e22-97ae-25b268d9bd76","slug":"changes","fullItemName":"Changes"},{"id":"2a520e88-6970-5c6c-81ab-6f85a403dbdf","slug":"update","fullItemName":"Update"}]},{"id":"e7b1ffd6-53e0-5248-9ef9-c3d9335bcaf8","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"afea2557-003c-5cab-9d6a-1843fad84de1","slug":"goals","fullItemName":"Goals"},{"id":"84c298f8-a5b4-5f98-b2ff-15a45fcb4f26","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"f21fc58c-8a25-5b15-a6bc-e737e68b787c","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"d379cce3-06f5-500f-8022-947483b96061","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"5e716806-4895-5480-a837-2377a13b6842","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"3da2e4cd-2a4d-5ed8-9747-eb0ca53b146d","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"5ea41579-133a-58f2-84ff-408513f6ec84","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"31ec7fd5-e27e-52f3-b236-31efd054a396","slug":"definition","fullItemName":"Definition"},{"id":"2a023940-e489-5105-8632-13827c70ea6a","slug":"causes-of-breast-pain","fullItemName":"Causes of breast pain"},{"id":"9c0c022a-236d-5b78-8edb-8e7db2f37e29","slug":"causes-of-nipple-pain","fullItemName":"Causes of nipple pain"},{"id":"223571de-a0b7-5f12-bec5-8a80ace52548","slug":"causes-of-low-milk-supply","fullItemName":"Causes of low milk supply"},{"id":"83d5346e-7f4a-522d-9773-4a6dd40c604e","slug":"causes-of-milk-oversupply","fullItemName":"Causes of milk oversupply"}]},{"id":"82725ef1-b602-5cb0-9269-61529b6c2b02","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"b1de0ed8-0423-5ead-aa5d-5cff64d0c321","slug":"assessment","fullItemName":"Assessment"},{"id":"472503aa-271b-514d-b4de-814e67a7a751","slug":"diagnosis-of-breast-pain","fullItemName":"Diagnosis of breast pain"},{"id":"4cc8cba0-c1f6-58b0-a13b-89abe37d504a","slug":"diagnosis-of-nipple-pain","fullItemName":"Diagnosis of nipple pain"},{"id":"f5afa158-bf6a-5287-91d4-87b5c001b13f","slug":"diagnosis-of-low-milk-supply","fullItemName":"Diagnosis of low milk supply"},{"id":"f8136aa4-95ef-5fdd-be27-e87dd0245585","slug":"diagnosis-of-milk-oversupply","fullItemName":"Diagnosis of milk oversupply"}]},{"id":"ca97794b-54f8-5bef-80ca-c5524975c2ad","fullItemName":"Management","slug":"management","subChapters":[{"id":"f9f8c0db-f1cc-552d-94f3-3bf6fc0028c5","slug":"breastfeeding-problems-management","fullItemName":"Scenario: Breastfeeding problems - management"}]},{"id":"1cfd7617-7b51-58ed-ab16-896215c43349","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"8bef9e53-ca1d-5b61-8b12-8b014e6bd3ec","slug":"paracetamol","fullItemName":"Paracetamol"},{"id":"1eaac104-bf91-5b86-afd3-c5d5437e4e93","slug":"flucloxacillin","fullItemName":"Flucloxacillin"},{"id":"4727ad63-3ff6-54b1-867f-894d33d550d2","slug":"erythromycin-clarithromycin","fullItemName":"Erythromycin and clarithromycin"},{"id":"6cd5a8b3-d7ea-577c-919e-0e1050c25ada","slug":"fluconazole","fullItemName":"Fluconazole"},{"id":"138c913a-c62a-5e10-9697-9f868ae99220","slug":"topical-fusidic-acid","fullItemName":"Topical fusidic acid"},{"id":"46d7af18-cc56-5707-8fcf-ae4b2bed882f","slug":"topical-miconazole","fullItemName":"Topical miconazole"}]},{"id":"c0e2db87-1126-5519-94ac-7719d6dc0798","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"409d7d9d-3f69-54b8-aa5c-eea89923ea9e","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"4d3d4c30-3488-5158-acfe-2d12bdb10359","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"49e75f6f-5655-58b1-8933-8fa4c3819b8a","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"d5b6c020-e109-5b11-aefd-70df672efa79","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"87720b05-a3b7-5a75-a206-9bfc4d167e76","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"cb469aba-1f15-5f6e-bfb6-fa073612150f","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"416d347c-3b3f-530d-8323-4bb4de52b3fe","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"2e3dcd26-e84a-59d0-8323-03f0685cd6a1","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?"},"subChapters":[{"id":"c74e8ef3-fa3f-5a85-b51b-1dbd2ebe439e","slug":"previous-changes","fullItemName":"Previous changes","depth":3,"htmlHeader":"<!-- begin field 17d3f9f6-ff3c-4565-b930-1be644f56e31 --><h3>Previous changes</h3><!-- end field 17d3f9f6-ff3c-4565-b930-1be644f56e31 -->","summary":null,"htmlStringContent":"<!-- begin item 97359a54-3615-4108-9c4b-9c804c35713d --><!-- begin field 7a70923e-03ee-4d40-bb3b-e8b8b23a2778 --><p><strong>May 2014 </strong>— minor update. The text has been updated to reflect advice from the UK Medicines Information Service and the European Medicines Agency regarding restrictions on prescribing domperidone.</p><p><strong>January 2014 </strong>— minor update. Text updated in line with the Summary of Product Characteristics (SPCs) for miconazole oral gel to highlight the risk of choking in infants and young children when miconazole oral gel is applied to the mouth.</p><p><strong>February 2013 </strong>— minor update. The 2013 QIPP options for local implementation have been added to this topic.</p><p><strong>June 2012 </strong>— minor update. Typographical error corrected in background information section.</p><p><strong>March 2012 </strong>—<strong> </strong>minor update. Information about the Department of Health's Healthy Start scheme and the importance for all breastfeeding women of taking a daily supplement containing 10 micrograms of vitamin D has been added. Issued in April 2012.</p><p><strong>January 2012 </strong>—<strong> </strong>minor update. McNeil Products Ltd, in collaboration with the Medicines and Healthcare products Regulatory Agency (MHRA), has published new safety data regarding the association of domperidone with an increased risk of serious ventricular arrhythmias or sudden cardiac death. This topic has been updated to reflect their advice on dosing, adverse effects, and drug interactions. Issued in February 2012.</p><p><strong>July 2011 </strong>— minor update. More exact paracetamol dosing for children has been introduced by the Medicines and Healthcare products Regulatory Agency (MHRA) following a press release (2011). Prescriptions have been updated to reflect the revised dosing. Issued in July 2011.</p><p><strong>June 2010 to February 2011 </strong>— this is a new CKS topic. The evidence-base has been reviewed in detail, and recommendations are clearly justified and transparently linked to the supporting evidence.</p><!-- end field 7a70923e-03ee-4d40-bb3b-e8b8b23a2778 --><!-- end item 97359a54-3615-4108-9c4b-9c804c35713d -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}